---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-25-083793"
form_type: "8-K"
ticker: "AXSM"
cik: "0001579428"
company_name: "Axsome Therapeutics, Inc."
filed_at: "2025-06-09T23:59:59+00:00"
generated_at: "2026-05-19T17:10:05.210900+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.1
calibrated_materiality_score: 0.1
confidence: "high"
source: SEC EDGAR
---

# Axsome stockholders approve all four proposals at 2025 annual meeting

## Summary
- Elected Roger A. Jeffs as Class I director with 27.3M votes for, 8.1M withheld.
- Approved 2025 Long-Term Incentive Plan with 26.4M for, 8.9M against.
- Ratified Deloitte & Touche as auditor for FY2025 with 40.8M for, 225.7K against.
- Advisory say-on-pay passed with 34.8M for, 528.2K against.
- Approximately 84% of shares (41.4M of 49.2M) represented at meeting.

## SEC filing metadata
- accession: 0000950170-25-083793
- form_type: 8-K
- ticker: AXSM
- cik: 0001579428
- company_name: Axsome Therapeutics, Inc.
- filed_at: 2025-06-09T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.1
- calibrated_materiality_score: 0.1
- confidence: high
- sec_items: 5.07, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1579428/000095017025083793/0000950170-25-083793-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1579428/000095017025083793/axsm-20250606.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-25-083793
- JSON: https://secwatch.observer/filing/0000950170-25-083793.json
- Plain text: https://secwatch.observer/filing/0000950170-25-083793.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.